SuperworthPDS Biotechnology shares outstanding PDSB
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 55.7M
- On a year earlier
- +21.3%
- more shares
PDS Biotechnology had 55.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 21.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 51.5M | +38% |
| FY2024 | 37.5M | +18% |
| FY2023 | 31.7M | +9% |
| FY2022 | 29M | +2% |
| FY2021 | 28.4M | +28% |
| FY2020 | 22.3M | +322% |
| FY2019 | 5.3M | +47% |
| FY2018 | 3.6M | +129% |
| FY2017 | 1.6M | +8% |
| FY2016 | 1.4M | +1612% |
| FY2014 | 84.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 55.7M | +21% | |
| Q1 FY26 | 55.5M | +37% | |
| Q4 FY25 | 51.5M | +38% | |
| Q3 FY25 | 46.9M | +27% | |
| Q2 FY25 | 45.9M | +25% | |
| Q1 FY25 | 40.5M | +16% | |
| Q4 FY24 | 37.5M | +18% | |
| Q3 FY24 | 36.8M | +19% | |
| Q2 FY24 | 36.7M | +19% | |
| Q1 FY24 | 34.8M | +14% | |
| Q4 FY23 | 31.7M | +9% | |
| Q3 FY23 | 30.9M | +9% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on PDS Biotechnology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.